Mobile

A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European populat...

Update Il y a 4 ans
Reference: EUCTR2011-000045-20

A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The objective of the study is to confirm in a larger and less selected population (?real life conditions?) the positive risk-benefit balance observed with silodosin 8 mg in double-blind, randomised clinical trials. El objetivo del estudio es confirmar en una población más grande y menos seleccionada ("condiciones de vida real") el balance riesgo-beneficio positivo observado con silodosina 8 mg en ensayos clínicos aleatorizados a doble ciego.

Inclusion criteria

  • benign prostatic hyperplasia,Hiperplasia prostática benigna

Links